These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 19204654

  • 1. Early symptom change prediction of remission in depression treatment.
    Katz MM, Meyers AL, Prakash A, Gaynor PJ, Houston JP.
    Psychopharmacol Bull; 2009; 42(1):94-107. PubMed ID: 19204654
    [Abstract] [Full Text] [Related]

  • 2. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA, Greist JH, Mallinckrodt CH, Prakash A, Sambunaris A, Tollefson GD, Wohlreich MM.
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [Abstract] [Full Text] [Related]

  • 3. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA, Prakash A, Arnold LM, Aaronson ST, Mallinckrodt CH, Wohlreich MM.
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [Abstract] [Full Text] [Related]

  • 4. Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.
    Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.
    Clin Drug Investig; 2007 Jun; 27(7):481-92. PubMed ID: 17563128
    [Abstract] [Full Text] [Related]

  • 5. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).
    Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M.
    Neuropsychobiology; 2007 Jun; 56(2-3):73-85. PubMed ID: 18037817
    [Abstract] [Full Text] [Related]

  • 6. Escitalopram and duloxetine in the treatment of major depressive disorder: a pooled analysis of two trials.
    Lam RW, Andersen HF, Wade AG.
    Int Clin Psychopharmacol; 2008 Jul; 23(4):181-7. PubMed ID: 18545055
    [Abstract] [Full Text] [Related]

  • 7. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW, Lönn SL, Despiégel N.
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder.
    Brecht S, Kajdasz D, Ball S, Thase ME.
    Int Clin Psychopharmacol; 2008 Nov; 23(6):317-24. PubMed ID: 18854719
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 14. Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.
    Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.
    J Sex Med; 2007 Jul; 4(4 Pt 1):917-29. PubMed ID: 17627739
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Baseline severity of depression predicts antidepressant drug response relative to escitalopram.
    Kilts CD, Wade AG, Andersen HF, Schlaepfer TE.
    Expert Opin Pharmacother; 2009 Apr; 10(6):927-36. PubMed ID: 19317630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
    Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM.
    J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Attributes of response in depressed patients switched to treatment with duloxetine.
    Sagman D, McIntosh D, Lee MS, Li H, Ruschel S, Hussain N, Granger RE, Lee AC, Raskin J.
    Int J Clin Pract; 2011 Jan; 65(1):73-81. PubMed ID: 21078010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.